Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11787793 Heterocyclic compounds as immunomodulators

Patent 11787793 was granted and assigned to Incyte on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor
0
Edits on 12 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11866435 Heterocyclic compounds as immunomodulators
0
Edits on 19 Oct, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 19 Oct, 2023
Edits made to:
Infobox (+51 properties)
‌

 US Patent 11787793 Heterocyclic compounds as immunomodulators

Infobox
Is a
Patent
Patent
Patent Applicant
Incyte
Incyte
Current Assignee
Incyte
Incyte
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11787793
Patent Inventor Names
Jingwei Li
Liangxing Wu
Wenqing Yao
Date of Patent
October 17, 2023
Patent Application Number
17672351
Date Filed
February 15, 2022
Patent Citations
‌
US Patent 11124511 Heterocyclic compounds as immunomodulators
‌
US Patent 7320989 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
‌
US Patent 7417065 Immunosuppressant compounds and compositions
‌
US Patent 7488802 Antibodies against PD-1
‌
US Patent 7491245 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
‌
US Patent 7691870 Benzimidazole carboxamides as raf kinase inhibitors
‌
US Patent 7851489 Pyridinone compounds
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
‌
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
‌
US Patent 8163743 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
‌
US Patent 8168757 PD-1 binding proteins
‌
US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
‌
US Patent 8541424 Anti-viral compounds
‌
US Patent 8993604 Treatment and prevention of dengue virus infections
‌
US Patent 9085576 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
‌
US Patent 9163017 Anti-viral compounds
‌
US Patent 9394365 Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
‌
US Patent 9540322 MIF modulators
‌
US Patent 9603950 Compounds of imaging agent with HDAC inhibitor for treatment of Alzheimer syndrome and method of synthesis thereof
‌
US Patent 9611261 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
‌
US Patent 9643922 MIF modulators
‌
US Patent 10017520 Myc modulators and uses thereof
‌
US Patent 10202343 MIF modulators
‌
US Patent 10308644 Heterocyclic compounds as immunomodulators
‌
US Patent 10618916 Heterocyclic compounds as immunomodulators
‌
US Patent 10669271 Heterocyclic compounds as immunomodulators
‌
US Patent 10793565 Heterocyclic compounds as immunomodulators
‌
US Patent 10800768 Heterocyclic compounds as immunomodulators
‌
US Patent 10806785 Immunomodulator compounds and methods of use
‌
US Patent 10906920 Heterocyclic compounds as immunomodulators
‌
US Patent 11339149 Heterocyclic compounds as immunomodulators
‌
US Patent 11401279 Pyrido[3,2-d]pyrimidine compounds as immunomodulators
‌
US Patent 11407749 Heterocyclic compounds as immunomodulators
‌
US Patent 11414433 Heterocyclic compounds as immunomodulators
‌
US Patent 11465981 Heterocyclic compounds as immunomodulators
‌
US Patent 11566026 Heterocyclic compounds as immunomodulators
‌
US Patent 11572366 Heterocyclic compounds as immunomodulators
‌
US Patent 11608337 Heterocyclic compounds as immunomodulators
‌
US Patent 6867200 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
Patent Primary Examiner
‌
Samantha L Shterengarts

Find more entities like US Patent 11787793 Heterocyclic compounds as immunomodulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo